Vivelix Pharmaceuticals, Ltd.

It could still be another five years before InDex Pharmaceuticals Holding AB gets approval for its ulcerative colitis (UC) drug cobitolimod but the Swedish biotech has already laid out specific laun

IN VITRO DIAGNOSTICS Alliances Allergan PLC T2 Biosystems Inc. T2 Biosystems Inc. and Allergan PLC are teaming up to develop a diagnostic panel to detect Gram-negative bacteria and antibiotic

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Nov. 21 and Dec. 2.